David J. Glass, Ph.D.
Curriculum Vitae

Summary of Experience and Accomplishments

• Over 30 years of diverse management experience in several fields of biotechnology, including medical, agricultural and environmental applications.
• Longstanding expertise in industrial, environmental and agricultural biotechnology regulatory affairs. Currently directing regulatory affairs for a leading renewable fuels company. Earlier in career, obtained several of the earliest approvals for field tests of genetically modified agricultural microorganisms and transgenic plants. Advised companies on the impact of biotechnology regulation on the uses of engineered microbes in hazardous waste treatment and biofuel production.
• Leadership roles in technology transfer at Harvard Medical School-affiliated institutions, including a senior management role in a large, active tech transfer office (Massachusetts General Hospital); and originating and directing in-house tech transfer functions at two smaller Harvard affiliates (McLean Hospital and Joslin Diabetes Center).
• Technology transfer experience includes negotiation of sponsored research and license agreements for biomedical technologies; successful environmental biotechnology partnering projects; liaison to corporate research sponsors and licensees, including companies in Japan and Europe; other international business experience. Awarded Certified Licensing Professional (CLP^TM) certification in July 2008.
• Managed intellectual property programs both in industry and academia, including responsibility for a portfolio of over 300 biomedical patent applications.
• Excellent communications skills, including over 70 speaking appearances, testimony before congressional and state legislative committees, and extensive media interactions. Authored over twenty professional articles and ten market reports on various topics in biotechnology, bioremediation and phytoremediation.

Professional Experience

Current Position

May 2011 to present

October 1990 to October 2011

D. Glass Associates, Inc., Needham, Massachusetts.

Beginning in October 1990, David Glass pursued a variety of consulting activities through D. Glass Associates, Inc., in the fields of bioremediation, phytoremediation, environmental, industrial and agricultural biotechnology regulatory affairs, as well as licensing, technology transfer and strategic patent management. Early activities focused primarily on projects involving regulatory affairs and market analyses in environmental and agricultural biotechnology. Advised Envirogen, Inc. and other companies on regulation of environmental and industrial biotechnology, assisted a multinational company identify potential European partners for a bioremediation product, advised several companies in the U.S. and Europe on the structure of bioremediation markets. Authored seven market reports for Decision Resources, Inc., authored and published two market reports on phytoremediation, and wrote numerous other articles and reports. Presented keynote speech at Third International Bioreclamation Symposium, April 1995, on international bioremediation activities, and numerous presentations (many invited) on U.S. and international phytoremediation markets at conferences sponsored by International Business Communications (IBC), the Association for the Environmental Health of Soils (AEHS), Battelle, and others.

From April 2001 to October 2011, Dr. Glass's activities focused to a greater degree on licensing and technology transfer in the fields of biotechnology, biomedicine and medical devices. During this time, Dr. Glass  assisted academic institutions with technology transfer and their intellectual property programs, and he advised several small companies on academic relations, strategic patent management, and other matters. Clients and assignments during this period include:

McLean Hospital, Belmont, Mass. (April 2001 to October 2005 as consultant; November 2005 to October 2011 as part-time employee). In-house management of technology transfer as a consultant, prior to becoming Senior Associate Director, Technology Transfer in November 2005.

Joslin Diabetes Center, Boston, Mass. (July 2001 to September 2006 as consultant; October 2006 to May 2011 as part-time employee). In-house management of technology transfer as a consultant, prior to becoming Director, Technology Transfer in October 2006.

Baystate Medical Center, Springfield, Mass. (September 2005 to October 2011). Assist in evaluation and marketing of inventions, and in the creation of tech transfer capability, with the title of Director of Technology Transfer from November 2006 to present. Also represented the Pioneer Valley Life Sciences Institute, a joint venture of Baystate and UMass Amherst, on similar tech transfer projects, from January to October 2011. 

Academia Sinica, Taipei, Taiwan (September 2001 to March 2003). Assisted a prominent Asian research institute seek U.S. and European licensees for medical and biotechnology inventions.

Intermountain HealthCare, Inc., Salt Lake City, Utah (March 2003 to March 2007). Helping a well-regarded regional healthcare center establish a technology licensing office, by analyzing current needs, recommending action items, and carrying out specific tech transfer projects.

Massachusetts General Hospital, Boston, Mass. (June 2002 to December 2007). Assistance negotiating license and sponsored research agreements.

Brigham and Women’s Hospital, Boston, Mass. (July 2004 to December 2006). Occasional assistance negotiating license, sponsored research and material transfer agreements.

Nanoframes, Inc., Boston, Mass. (April 2001 to June 2004). Carried out negotiations with founding academic institution, assist in management of patent portfolio.

PureTech Ventures, LLC, Boston, Mass. (May 2001 to present). Advise and assist on matters relating to intellectual property licensed by portfolio companies from academic institutions.

Keel Pharmaceuticals, Inc., Cambridge, Mass. (June 2002 to present). Assist in negotiations with academic licensing partner, strategic management of patent portfolio.

ENS Biopolymers, LLC, Cambridge, Mass. (January 2003 to April 2007). Carry out negotiations with founding university, assist in discussions with potential corporate partners.

April 2001 to October 2005

Chief Executive Officer, Applied PhytoGenetics, Inc., Athens, Georgia.

Recruited by founders to become first CEO of a small company pursuing phytoremediation – the use of trees and plants to remove hazardous contaminants from the environment. Initial responsibilities include redrafting business plan, raising initial rounds of funding, supervising the growth of company from founders-stage to early-stage development, lead and participate in business development efforts, in-licensing from founding academic institution, and other general management responsibilities. Part-time position.

January 1999 to April 2001

Associate Director, Corporate Sponsored Research and Licensing, Massachusetts General Hospital, Boston, Massachusetts.

Technology transfer responsibilities for an internationally-known teaching hospital with a large professional research staff, and its affiliated psychiatric hospital the McLean Hospital. Responsibility, along with a staff of three Ph.D.-level tech transfer professionals, for managing the hospital's invention and patent program, and carrying out much of its non-software technology licensing. Drafted and negotiated technology licenses and other industry-academia agreements.

May 1991 to December 1998

Associate Director for Patents, Office of Technology Affairs, Massachusetts General Hospital, Boston, Massachusetts.

Technology transfer responsibilities for an internationally-known teaching hospital with a large professional research staff, and its affiliated psychiatric hospital the McLean Hospital. Managed the hospital's patent portfolio, including evaluation of new disclosures, strategic direction of patent prosecution and liaison to U.S. and foreign licensees. Drafted and negotiated legal agreements for patent licenses and industry-sponsored research.

February 1988 to October 1990

Vice President, Government and Regulatory Affairs, BioTechnica Agriculture, Cambridge, Massachusetts.

Responsible for all matters of regulatory compliance, community relations and government relations for the agricultural subsidiary of BioTechnica International, with supervision over intellectual property protection and regulatory affairs for the parent company. Obtained regulatory approval for several field tests of transgenic plants and microbes. Recognized as an industry spokesman for agricultural and food biotechnology public policy issues.

April 1983 to February 1988

Director, Patents and Regulatory Affairs, BioTechnica International, Cambridge, Massachusetts.

Responsibilities included development and implementation of the company's program of intellectual property protection, regulatory compliance in a variety of product areas and liaison to trade associations. The primary regulatory project was an application to conduct a field test of a genetically engineered agricultural microorganism, which involved a program of community relations and media relations at the test site.

July 1981 to March 1983

Executive Assistant and Research Scientist, BioTechnica International, Cambridge, Massachusetts.

Responsibilities included biosafety, radiation safety, technical writing, and other administrative duties.

January 1981 to June 1981

Freelance Science Writer, with publications in Science Digest, BioScience.

Education

Princeton University, Princeton, New Jersey
Department of Biochemical Sciences
M.A., 1978, Ph.D., 1981

Cornell University, Ithaca, New York
Major: Biological Sciences
B.S., 1975

Congressional Testimony and Government Workshops and Committees

Subcommittee on Department Operations, Research and Foreign Agriculture, U.S. House Committee on Agriculture, Testimony on proposed bill H.R. 5312, Washington, D.C., October 2, 1990.

Subcommittee on Hazardous Wastes and Toxic Substances, U.S. Senate Committee on the Environment and Public Works, Testimony on adequacy of federal regulatory framework, Washington, D.C., November 5, 1987.

Office of Technology Assessment, Workshop on Factors Affecting Commercialization and Innovation in Biotechnology, Washington, D.C., June 11, 1987.

Subcommittees on Natural Resources, Agriculture Research and Environment; and on Science, Research and Technology, U.S. House of Representatives, Testimony on proposed bill H.R. 4452, Washington, D.C., June 5, 1986.

Member, Wisconsin State Assembly, Subcommittee on Genetic Engineering, 1987-1988.

Member, Minnesota State Government, Advisory Committee on Biotechnology Regulations, 1989 to 1990.

Memberships and Certifications

Awarded Certified Licensing Professional (CLP^TM) certification in July 2008.

Massachusetts Biotechnology Council; President, April 1988 to April 1990. Vice President, April 1987 to March 1988. Secretary, March 1985 to March 1987. Member, Board of Directors, March 1985 to March 1991. Chairman, Regulatory Affairs Committee, 1985 to 1987.

Industrial Biotechnology Association; various committee memberships, 1983 to 1990. Chairman, EPA Relations Committee, November 1988 to October 1990. Chairman, Food Biotechnology Public Relations Subcommittee, May 1988 to January 1990.

International Food Biotechnology Council, Member of Executive Committee and Board of Directors, February 1988 to February 1991.

Member, Board of Directors, Massachusetts Medical Device Industry Council (MassMEDIC), May 1997 to April 2001.

Member, Editorial Board, International Journal of Phytoremediation, June 1998 to present.

Member, Editorial Board, Journal of Soils and Sediments, January 2001 to present.

Individual Member, Applied Biotreatment Association, 1990 to 1992. Corporate Member, Environmental Business Council, March 1991 to March 1992; January 1993 to March 1994.

Chair, Needham, Mass. Biotechnology Advisory Committee, October 1995 to May 1996.

Member, Licensing Executives Society. Member, Association of University Technology Managers.

Bureau of National Affairs, Member, Advisory Board for Special Report Series on Biotechnology, 1989, 1990. Member, Biotechnology Working Group, Kennedy School of Government, 1991 to 1995.

American Society for Testing and Materials, Committee E-48 on Biotechnology; Secretary, Subcommittee E-48.04 on Environmental Issues; Chair, task group E-48.04.1 on Monitoring and Detection, 1985-1987.

[Publications]

[Selected Speaking Appearances]